Skip to content

Opko Health OPK Total debt

Total debt at other companies

Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$956K-16.7%
HRO
HarrowHROW
$308.58M-32.9%
Precigen logo
PrecigenPGEN
$98.25M+1,714%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Quest Diagnostics logo
Quest DiagnosticsDGX
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Plus components not separately reported this period.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's total debt?
Opko Health (OPK) reported total debt of $52.78M in Q1 2026.
How has Opko Health's total debt changed year-over-year?
Opko Health's total debt decreased by 4.2% year-over-year, from $55.07M to $52.78M.
What is the long-term trend for Opko Health's total debt?
Over 5 years (2020 to 2025), Opko Health's total debt has grown at a 1.6% compound annual growth rate (CAGR), from $50.34M to $54.55M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.